Skip to main content
Clinical Trials/ITMCTR2200005825
ITMCTR2200005825
Completed
未知

A randomized, double-blind and controlled study of clearing heat and resolving depression in the treatment of bipolar depression and fire heat depression

Overview

Phase
未知
Intervention
Not specified
Conditions
Bipolar disorder
Sponsor
Beijing Anding Hospital, Capital Medical University
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • ? The diagnosis of bipolar disorder was evaluated by structured clinical interview for DSM\-IV Axis I disorders (SCID\-I / P). Bipolar disorder was diagnosed according to DSM\-IV diagnostic criteria and is currently a depressive episode; ? Age 18\-40 years; ? 24 items Hamilton Depression Scale (hamd\-24\) \= 20 points, \= 35 points (lasting for 2 weeks), and Hamilton Anxiety Scale (HAMA) \= 7 points (lasting for more than 2 weeks); Young manic Rating Scale (YMRS) \= 5 points; ? Meet the diagnostic criteria of fire heat syndrome; ? Junior high school education or above; ? No somatic diseases and endocrine diseases; ? Have sufficient audio\-visual level to complete the examination necessary for the study; ? The patient and his guardian agreed and signed the informed consent form.

Exclusion Criteria

  • ? The possibility of bipolar depression caused by somatic diseases and endocrine diseases; ? The possibility of bipolar depression caused by psychoactive substances; ? Accompanied by other mental diseases, such as anxiety, schizophrenia, manic episode, obsessive\-compulsive disorder, etc; ? Patients with unstable vital signs and serious suicidal concept; ? Women breastfeeding, pregnant or preparing for pregnancy; ? Alcohol and drug dependence within 1 year; ? Those with a history of severe drug allergy; ? Those who have participated in clinical trials of other drugs within 30 days; ? Patients who had taken monoamine oxidase inhibitors within 4 weeks before enrollment, or patients treated with long\-acting mental blockers, or patients receiving hormone drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials